Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma

被引：1
|
作者：
Ozaki, Kai [1 ]
Hatakeyama, Shingo [2 ]
Hamaya, Tomoko [1 ]
Okita, Kazutaka [1 ]
Hashimoto, Yasuhiro [1 ]
Ohyama, Chikara [1 ,2 ]
机构：
[1] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan
[2] Hirosaki Univ, Grad Sch Med, Dept Adv Blood Purificat Therapy, Hirosaki, Aomori, Japan
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2022年 / 29卷 / 04期
基金：
日本学术振兴会;
关键词：
D O I：
10.1111/iju.14778
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：362 / 364
页数：3
相关论文
共 50 条
  • [41] First-line Immune Checkpoint Inhibitor Versus Immune Checkpoint Inhibitor With Chemotherapy for Cisplatin-ineligible Metastatic Urothelial Carcinoma: Evidence From a Real-world, Multicenter Analysis
    Lin, Chang-Ting
    Su, Po-Jung
    Huang, Shih-Yu
    Wu, Chia-Che
    Wang, Hung-Jen
    Cheng, Yuan-Tso
    Luo, Hao-Lun
    Chen, Chien-Hsu
    Liu, Ting-Ting
    Huang, Chun-Chieh
    Su, Yu-Li
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (09) : 407 - 414
  • [42] Efficacy of first-line immune checkpoint inhibitors in patients with sarcomatoid and/or rhabdoid (S/R) metastatic renal cell carcinoma (mRCC).
    Bakouny, Ziad
    Abou Alaiwi, Sarah
    Nassar, Amin
    Steinharter, John A.
    Wei, Xiao X.
    McGregor, Bradley Alexander
    Harshman, Lauren Christine
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [43] Tailored Selection of First-Line Cisplatin-Based Chemotherapy in Patients with Metastatic Urothelial Carcinoma of Bladder
    Hsieh, Meng-Che
    Huang, Cheng-Hua
    Chiang, Po-Hui
    Chen, Yen-Yang
    Tang, Yeh
    Su, Yu-Li
    JOURNAL OF CANCER, 2016, 7 (10): : 1347 - 1352
  • [44] The efficacy of immune checkpoint inhibitors therapy versus chemotherapy in the treatment of advanced and metastatic urothelial carcinoma: a meta-analysis
    Huang, Gaozhen
    Xiong, Hong
    Li, Shihao
    Zhu, Yi
    Liu, Hongwei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (01)
  • [45] First-line chemotherapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma
    Bongiovanni, Alberto
    Riva, Nada
    Ricci, Marianna
    Liverani, Chiara
    La Manna, Federico
    De Vita, Alessandro
    Foca, Flavia
    Mercatali, Laura
    Severi, Stefano
    Amadori, Dino
    Ibrahim, Toni
    ONCOTARGETS AND THERAPY, 2015, 8 : 3613 - 3619
  • [46] Expression of Programmed Cell Death Ligand 1 as a Predictive Biomarker in Metastatic Urothelial Carcinoma Patients Treated with First-line Immune Checkpoint Inhibitors Versus Chemotherapy: A Systematic Review and Meta-analysis
    Rizzo, Alessandro
    Mollica, Veronica
    Massari, Francesco
    EUROPEAN UROLOGY FOCUS, 2022, 8 (01): : 152 - 159
  • [47] OVERALL SURVIVAL IN PATIENTS WITH METASTATIC UROTHELIAL CANCER BY FIRST-LINE THERAPY
    Velde, Vander N. S.
    Guerin, A.
    Ionescu-Ittu, R.
    Shi, S.
    Wu, E.
    Lin, S.
    de Ducla, S.
    Wang, J.
    Li, S.
    Derleth, C.
    Leppert, J. T.
    Liu, S.
    Shi, L.
    VALUE IN HEALTH, 2017, 20 (09) : A421 - A421
  • [48] Sequential therapy versus first-line tyrosine kinase inhibitor plus immune checkpoint inhibitor therapy for unresectable hepatocellular carcinoma
    Ruan, Minghao
    Yang, Cheng
    Zhao, Jing
    Zhi, Kangkang
    Feng, Xiaochen
    Zhang, Jin
    Jin, Riming
    Li, Yao
    Wu, Dong
    Liu, Hui
    Sun, Wen
    Wang, Ruoyu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Association of biomarkers and outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with immune checkpoint inhibitors (ICIs).
    Reyes, Kevin R.
    Zhang, Li
    Zhu, Xiaolin
    Jindal, Tanya
    Deshmukh, Prianka
    de Kouchkovsky, Ivan
    Kumar, Vipul
    Maldonado, Edward
    Kwon, Daniel H.
    Chan, Emily
    Porten, Sima P.
    Borno, Hala
    Bose, Rohit
    Desai, Arpita
    Aggarwal, Rahul Raj
    Small, Eric Jay
    Fong, Lawrence
    Chou, Jonathan
    Friedlander, Terence W.
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [50] Conditional Survival of Patients Treated With First-Line Chemotherapy for Metastatic Urothelial Cancer
    Santoni, Matteo
    Crabb, Simon J.
    Conti, Alessandro
    Rossi, Lorena
    Burattini, Luciano
    Conteduca, Vincenza
    Chau, Caroline
    Burgio, Salvatore L.
    Muzzonigro, Giovanni
    Cascinu, Stefano
    De Giorgi, Ugo
    CLINICAL GENITOURINARY CANCER, 2015, 13 (03) : 244 - 249
12345